Pattern of comorbidities in school-aged children with cerebral palsy in Cross River State, Nigeria.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
08 04 2021
Historique:
received: 11 01 2021
accepted: 25 03 2021
entrez: 9 4 2021
pubmed: 10 4 2021
medline: 28 5 2021
Statut: epublish

Résumé

To describe the pattern of comorbidities in school-aged children with cerebral palsy (CP) and to identify which, if any, were associated with poor school attendance. A cross-sectional study, using the key informant methodology, between December 2017 and July 2018 was conducted in Cross River State, Nigeria. Assessments, confirmation of CP and identification of systemic comorbidities using standard tools and questionnaires were performed. Children confirmed to have CP between the ages 4 to 15 years were included. Three hundred and eighty-eight children were confirmed to have CP, 59% males. The mean age was 9.2 years ± SD 4.0; 28% were non-ambulatory (gross motor function classification system (GMFCS) level IV-V) and spastic CP was seen in 70%. Comorbidities included Speech impairment 85%, feeding difficulties 86%, and swallowing difficulties 77%, learning difficulties 88%, abnormal behaviour 62%, visual acuity impairment 54%, objective perceptual visual disorders 46%, communication difficulties 45%, epilepsy 35%, hearing impairment 12% and malnutrition 51%. Learning difficulties (OR 10.1, p < 0.001; CI: 3.6-28.1), visual acuity impairment (OR 2.8, p = 0.002; CI: 1.5-5.3), epilepsy (OR 2.3, p = 0.009; CI:1.2-4.3) manual ability classification scale 4-5 (OR 4.7,p = 0.049; CI:1.0-22.2) and CP severity (GMFCS V-VI) OR 6.9 p = 0.002, CI: 2.0-24.0.) were seen as increasing the likelihood of poor school attendance. Comorbidities were common, and some were associated with limited school attendance. A multidisciplinary tailored approach to care, with application of available therapeutic interventions for comorbidities is suggested. This may be useful in reducing barriers to school attendance.

Sections du résumé

BACKGROUND
To describe the pattern of comorbidities in school-aged children with cerebral palsy (CP) and to identify which, if any, were associated with poor school attendance. A cross-sectional study, using the key informant methodology, between December 2017 and July 2018 was conducted in Cross River State, Nigeria. Assessments, confirmation of CP and identification of systemic comorbidities using standard tools and questionnaires were performed. Children confirmed to have CP between the ages 4 to 15 years were included.
RESULTS
Three hundred and eighty-eight children were confirmed to have CP, 59% males. The mean age was 9.2 years ± SD 4.0; 28% were non-ambulatory (gross motor function classification system (GMFCS) level IV-V) and spastic CP was seen in 70%. Comorbidities included Speech impairment 85%, feeding difficulties 86%, and swallowing difficulties 77%, learning difficulties 88%, abnormal behaviour 62%, visual acuity impairment 54%, objective perceptual visual disorders 46%, communication difficulties 45%, epilepsy 35%, hearing impairment 12% and malnutrition 51%. Learning difficulties (OR 10.1, p < 0.001; CI: 3.6-28.1), visual acuity impairment (OR 2.8, p = 0.002; CI: 1.5-5.3), epilepsy (OR 2.3, p = 0.009; CI:1.2-4.3) manual ability classification scale 4-5 (OR 4.7,p = 0.049; CI:1.0-22.2) and CP severity (GMFCS V-VI) OR 6.9 p = 0.002, CI: 2.0-24.0.) were seen as increasing the likelihood of poor school attendance.
CONCLUSION
Comorbidities were common, and some were associated with limited school attendance. A multidisciplinary tailored approach to care, with application of available therapeutic interventions for comorbidities is suggested. This may be useful in reducing barriers to school attendance.

Identifiants

pubmed: 33832457
doi: 10.1186/s12887-021-02637-9
pii: 10.1186/s12887-021-02637-9
pmc: PMC8028192
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

165

Références

BMC Neurol. 2015 Sep 25;15:173
pubmed: 26407723
Dev Med Child Neurol. 2019 May;61(5):511-512
pubmed: 30828785
Int J Pediatr. 2014;2014:204386
pubmed: 24678321
Adv Data. 2000 Jun 8;(314):1-27
pubmed: 11183293
Arch Dis Child. 2014 Dec;99(12):1103-8
pubmed: 25005523
Indian J Pediatr. 2001 Feb;68(2):111-5
pubmed: 11284176
Indian Pediatr. 2001 Aug;38(8):839-46
pubmed: 11520994
Eur Child Adolesc Psychiatry. 2008 Dec;17(8):491-7
pubmed: 18431536
Eur J Clin Nutr. 2013 Dec;67 Suppl 2:S9-12
pubmed: 24301008
Dev Med Child Neurol. 2019 May;61(5):601-609
pubmed: 30394528
Br J Ophthalmol. 2022 Mar;106(3):427-434
pubmed: 33268343
Arch Phys Med Rehabil. 2005 May;86(5):940-5
pubmed: 15895340
Future Child. 2012 Spring;22(1):97-122
pubmed: 22550687
Indian J Psychiatry. 2019 Jan;61(Suppl 2):194-210
pubmed: 30745696
Eur J Pediatr. 2009 Apr;168(4):477-85
pubmed: 18551314
Child Adolesc Psychiatry Ment Health. 2018 Jan 11;12:6
pubmed: 29344084
Trials. 2019 Jul 10;20(1):417
pubmed: 31291989
Arch Dis Child. 2020 Jul;105(7):625-630
pubmed: 31959596
Soc Sci Med. 2003 Oct;57(8):1361-74
pubmed: 12927467
Semin Pediatr Neurol. 2004 Mar;11(1):5-10
pubmed: 15132248
Neurology. 2009 Jun 16;72(24):2090-6
pubmed: 19528515
Br J Ophthalmol. 2007 Aug;91(8):995-9
pubmed: 17431019
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
Disabil Rehabil. 2005 May 20;27(10):583-9
pubmed: 16019867
BMC Res Notes. 2015 Apr 23;8:166
pubmed: 25902796
Paediatr Child Health. 2004 Mar;9(3):174-88
pubmed: 19655005
Dev Med Child Neurol. 2018 Sep;60(9):914-921
pubmed: 29736993
J Trop Pediatr. 2012 Aug;58(4):269-74
pubmed: 22080830
Acta Ophthalmol Scand. 2006 Dec;84(6):807-11
pubmed: 17083543
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258
J Nutr Health Aging. 2008 Jan;12(1):39-43
pubmed: 18165843
Disabil Rehabil. 2012;34(13):1089-95
pubmed: 22136387
Lancet Glob Health. 2017 Dec;5(12):e1275-e1282
pubmed: 29102350
Niger Postgrad Med J. 2018 Jul-Sep;25(3):156-160
pubmed: 30264766
Dev Med Child Neurol. 2016 Mar;58(3):285-91
pubmed: 26272847
Ann Fam Med. 2009 Jul-Aug;7(4):357-63
pubmed: 19597174
J Child Neurol. 2005 Mar;20(3):175-80
pubmed: 15832604
Dev Med Child Neurol. 2006 Jun;48(6):442-9
pubmed: 16700934
J Neurol Neurosurg Psychiatry. 1987 Jul;50(7):829-39
pubmed: 3305790

Auteurs

Roseline E Duke (RE)

London School of Hygiene & Tropical Medicine, International Centre for Eye Health, London, UK. dr.roseineduek@gmail.com.
Department of Ophthalmology, University of Calabar Teaching Hospital, Calabar Children's Eye Centre, Calabar, Cross River State, Nigeria. dr.roseineduek@gmail.com.

Chimaeze Torty (C)

Department of Paediatrics, Neurology Unit, University of Calabar Teaching Hospital, Calabar, Nigeria.

Uche Okorie (U)

Department of Ophthalmology, University of Calabar Teaching Hospital, Calabar Children's Eye Centre, Calabar, Cross River State, Nigeria.

Min J Kim (MJ)

London School of Hygiene & Tropical Medicine, International Centre for Eye Health, London, UK.

Nnena Eneli (N)

Department of Physiotherapy, University of Calabar Teaching Hospital, Calabar, Nigeria.

Ukam Edadi (U)

Primary Health Care Development Agency, Calabar, Cross River State, Nigeria.

Kathryn Burton (K)

Cambridgeshire Community Services, Cambridge, UK.

Cally Tann (C)

Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK.

Richard Bowman (R)

London School of Hygiene & Tropical Medicine, International Centre for Eye Health, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH